|
|
|
|
|
Received: 10 February 2018
|
|
|
|
|
|
| [1] |
姚 英,章友康,王素霞. AL型肾淀粉样变的临床病理特点和治疗进展[J]. 中华临床医师杂志,2012, 6(15):4180-4181.
|
| [2] |
Verine J, Mourad N, Desseaux K, et al. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response [J]. Human Pathol, 2007, 38: 1798-1809.
|
| [3] |
Sanchorawala V,Skinner M,Quillen K,et al.Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantatio[J]. Blood, 2007, 110(10):3561-3563.
|
| [4] |
Hopfer H, Wiech T, Mihatsch M J. Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type [J]. Nephrol Dial Transpl, 2011, 26: 2877-2884.
|
| [5] |
Sethi S, Theis J D, Leung N, et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis [J]. Clin J Am Soc Nephrol,2010, 5: 2180-2187.
|
|
|
2018, Vol. 29 
